It is referred to as a focused therapy because it specially targets the CD38 which can be overexpressed on the multiple myeloma cells. Daratumumab is from a class of medicines referred to as CD38 monoclonal antibodies. Animal studies have joined semaglutide to thyroid C-cell tumors, although the danger in humans https://adhdozempic.com/